stars 1 stars 2 stars 3

OcuMedic, Inc. is the developer of the world's first drug-eluting therapeutic lens/clear corneal bandage for the delivery of drugs for the global ophthalmic market. Invented by Mark Byrne, Ph.D., distinguished engineering professor and Founding Head of the Department of Biomedical Engineering at Rowan University, the therapeutic lens is a soft contact developed in the most widely used safe lens material that precisely controls the release of a "first line" anti-inflammatory drug that targets post-operative eye care to reduce healing time and costly complications. The device is a platform technology, with OcuMedic demonstrating controlled release of a number of therapeutics for the duration of wear, targeted at the large and growing surgery, dry eye, corneal abrasion, and glaucoma markets.

Website http://ocumedic.us
Revenue $5 million
Employees View employees
Founded 2006
Address 107 Gilbreth Pkwy, Mullica Hill, New Jersey 08062, US
Phone +1 404-444-6030
Industry Biotechnology, Drug Delivery, Science and Engineering, Other Devices and Supplies, Medical, Health Care
Competitors Novartis, Abbott, Optum, Alcon, ZEISS Group, Bausch + Lomb, Iridex, EyePoint Pharmaceuticals, Aerie Pharmaceuticals, Hoya Vision Care +24 more (view full list)

OcuMedic, Inc. Questions

The OcuMedic, Inc. annual revenue was $5 million in 2026.

OcuMedic, Inc. is based in Mullica Hill, New Jersey.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users